INTRODUCTION
In an attempt to characterize the role of mTOR pathway in the neurobiology of this mood disorder, we silenced the expression of mTOR in mPFC, specifically in the infralimbic and prelimbic cortices (IL and PL), since the modulation of neuronal activity in the IL underlies the antidepressant and anxiolytic actions of ketamine [5] .
AIM OF THE STUDY
Animals. Adult male C57Bl/6J mice of 8-10 weeks of age. siRNAs. A pool of two different small interfering RNA molecules specifically designed against mTOR were used (mTOR-siRNA). Intracerebral siRNA infusion. Mice were anesthetized with pentobarbital (40 mg·kg -1 ) and artificial cerebrospinal fluid (aCSF) or mTOR-siRNA were stereotaxically infused unilaterally into IL cortex (AP: +2.2, ML: -0.2 and DV: -3.4), and PL cortex (AP: +2.0, ML: -0.2 and DV: -2.0). Mice were sacrificed 48 h post-infusion. Forced swimming test (FST). Mice were placed in swimming tanks (12 cm diameter x 24 cm tall), filled with water at 25-27°C. Each mouse was placed individually in the swimming tank for a single 6 min session. The immobility time was scored using a video camera system. Tail suspension test (TST). Mice were suspended 30 cm above the bench by the tip of the tail during a 6 min session in which the total duration of immobility was measured. Open field test (OF). Mice were placed in open field boxes (35x35x40 cm) indirectly illuminated (25-40 luxes) during 15 min. The motor activity was recorded (Videotrack, View Point, France) and the total distance (m), and percentage time in the centre of the arena were analysed. Intracerebral microdialysis. Extracellular serotonin (5-HT) levels were analysed by in vivo microdialysis 24 h post siRNA infusion. The aCSF+1μM Citalopram, 50μM veratridine and 100μM bicuculine were pumped (WPI model, SP220i) at 1.5 μl·min -1 and samples were collected every 20 min. 5-HT perisomatic levels were analysed by high-performance liquid chromatography. In situ hybridization (ISH). Mice were sacrificed and brains rapidly removed and frozen in dry-ice. 14 μm thick coronal tissue sections were cut and mounted onto 3-aminopropyltriethoxysilane pre-treated slides. Mouse mTOR and BDNF oligoprobes used were individually labelled (2 pmol) at the 3' end with [ 33 P]-dATP (DuPont-NEN) using terminal TdT (Calbiochem). Tissue sections were hybridized as previously described [6] and exposed to Biomax-MR film (Kodak, Madrid), during 7days for mTOR and 2 days for BDNF. Optical densities were obtained using a computer assisted image analyser. Statistical analysis. Groups were statistically compared by Student t-test or two-way ANOVA followed by Newman-Keuls posthoc test. Data are expressed as mean±S.E.M.
METHODS

RESULTS
Depressive-like behaviour in mice unilaterally infused intra-IL cortex with mTOR siRNAs. FST (A) and TST (C) (24 and 48 hours respectively after silencing). In contrast animals infused in PL, did not show alterations in depressive-like behaviour (B and D). Silenced animals did not show alterations in locomotor activity (E and F). Student's t-test; **p<0.01. n=6-9 animals/group. Reduction in mTOR mRNA expression in PL cortex after the unilateral administration of mTOR-siRNAs into PL cortex. PL cortex (C). Two-way ANOVA followed by Newman-Keuls post-hoc test; *p ˂ 0.05, **p < 0.01, ***p < 0.001 vs aCSF-IL-ipsi. n=5 animals per group.
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Reduction in mTOR mRNA expression in IL and PL cortices after the unilateral administration of mTORsiRNAs into IL cortex. IL (A) and PL cortex (B). Twoway ANOVA followed by Newman-Keuls post-hoc test; *p ˂ 0.05, ***p < 0.001 vs aCSF-IL-ipsi; ##p<0.01 vs aCSF-IL-contra. n=5 animals per group.
The present study suggests that the mTOR pathway in IL cortex, but not in PL cortex, plays a major role in the depressive-like behaviour. This allows a better understanding of the biological basis of MDD and new approaches to antidepressant drug discovery.
CONCLUSIONS
